x
Breaking News
0

Lupin Ltd (LUPN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
847.50 +2.25    +0.27%
09:42:52 - Real-time Data. Currency in INR ( Disclaimer )
Type: Equity
Market: India
ISIN: INE326A01037 
S/N: LUPIN
  • Volume: 114,989
  • Bid/Ask: 847.30 / 847.45
  • Day's Range: 843.60 - 851.40
Start Trading
Lupin 847.50 +2.25 +0.27%

LUPN Overview

 
Information about the Lupin Ltd Share. You can find more details by going to one of the sections listed on this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close845.25
Day's Range843.6 - 851.4
Revenue165.58B
Open845.65
52 wk Range806.25 - 1,573.6
EPS40.31
Volume114,989
Market Cap382.02B
Dividend (Yield)7.5 (0.89%)
Average Volume (3m)2,245,376
P/E Ratio20.97
Beta - 0.03
1-Year Change - 43.44%
Shares Outstanding451,960,349
Next Earnings DateFeb 05, 2018
What is your sentiment on Lupin?
or
Vote to see community's results!

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Neutral Strong Sell
Technical Indicators Strong Buy BUY BUY Strong Buy Strong Sell
Summary Strong Buy Buy Buy Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Engulfing Bearish 15 Current
Three Inside Up 1W Current
Completed Patterns
Engulfing Bearish 5H 2 Dec 13, 2017 13:30
Bullish doji Star 1H 2 Dec 13, 2017 15:30
Engulfing Bearish 1H 4 Dec 13, 2017 13:30

Lupin Ltd News & Analysis

Lupin Ltd Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NSE 847.50 847.30 847.45 114,989 +0.27% INR 09:42:52  
  NSE 848.85 0.00 0.00 214,800 +0.28% INR 09:41:00  
  BSE 847.70 847.00 847.70 2,385 +0.49% INR 09:27:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Tata Communications 722.25 754.00 720.10 +25.85 +3.71% 2.65M 09:42:37  
  Vedanta 285.10 288.05 284.75 +1.55 +0.55% 1.40M 09:42:54  
  Tech Mahindra 514.45 518.15 503.00 +10.85 +2.15% 1.06M 09:42:55  
  Oil & Natural Gas 184.70 186.70 184.25 +0.80 +0.44% 951.89K 09:43:06  
  Sun TV Network Ltd 916.00 929.85 913.80 -0.25 -0.03% 459.13K 09:42:49  
  AVT Natural Products Ltd 55.75 57.30 54.80 +1.40 +2.58% 802.02K 09:42:58  
  SBI 313.75 315.40 313.15 +0.45 +0.14% 1.62M 09:42:54  
  Punjab National Bank 167.95 169.35 167.45 +0.15 +0.09% 1.43M 09:42:43  
  Bharat Petroleum 512.80 513.00 508.00 +6.50 +1.28% 403.94K 09:42:49  
  Hindustan Petroleum 428.40 428.55 425.00 +5.05 +1.19% 370.88K 09:43:03  

Lupin Ltd Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

16792

Equity Type

ORD

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives and non-steroidal anti-inflammatory drug therapy areas. The Company also offers solutions in the anti-tuberculosis (anti-TB) and cephalosporins therapy areas. The Company along with its subsidiaries has manufacturing locations spread across India, Japan, the United States, Mexico and Brazil. It has a pipeline of biosimilars addressing therapies, such as oncology, anti-inflammatory, anti-viral, rheumatoid arthritis, endocrinology, diabetes, ophthalmology and women's health. The Company's products include Antara, Methergine, Methylphenidate, Glumetza, Gluconorm, Tonact, Rcinex and Ramistar, among others.

Read More

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Lupin Ltd
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest LUPN Comments

somu muthu
somu muthu Nov 15, 2017 6:13 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very important support 813 close below this for two days next target ****
Reply
0 0
Jay Rathod
Jay Rathod Nov 13, 2017 6:08 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy lupin.. 930..stop loss 923 .. Will be see high in coming days atleast 975
Reply
1 0
BS Negi
BS Negi Oct 30, 2017 8:52 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy and hold upto 1466
Reply
0 0
Show more comments
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email